These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22031471)

  • 21. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE; Haddjeri N; Debonnel G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
    Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.
    Scorza MC; Lladó-Pelfort L; Oller S; Cortés R; Puigdemont D; Portella MJ; Pérez-Egea R; Alvarez E; Celada P; Pérez V; Artigas F
    Br J Pharmacol; 2012 Nov; 167(5):1021-34. PubMed ID: 22050051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
    Ashby CR; Kehne JH; Bartoszyk GD; Renda MJ; Athanasiou M; Pierz KA; Seyfried CA
    Eur J Pharmacol; 2013 Aug; 714(1-3):359-65. PubMed ID: 23872377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S; Graf M; Anheuer ZE; Bagdy G
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
    Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
    J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.
    Martin V; Mathieu L; Diaz J; Salman H; Alterio J; Chevarin C; Lanfumey L; Hamon M; Austin MC; Darmon M; Stockmeier CA; Masson J
    J Psychiatry Neurosci; 2020 Sep; 45(5):344-355. PubMed ID: 32459080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered serotonergic function of dorsal raphe nucleus in perinatally protein-deprived rats: effects of fluoxetine administration.
    Sodero AO; Orsingher OA; Ramírez OA
    Eur J Pharmacol; 2006 Feb; 532(3):230-5. PubMed ID: 16472801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do 5-HT1B/1D autoreceptors modulate dorsal raphe cell firing? In vivo electrophysiological studies in guinea pigs with GR127935.
    Sprouse J; Reynolds L; Rollema H
    Neuropharmacology; 1997; 36(4-5):559-67. PubMed ID: 9225281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
    Pejchal T; Foley MA; Kosofsky BE; Waeber C
    Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.
    Descarries L; Riad M
    Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2416-25. PubMed ID: 22826342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain.
    Popa D; Cerdan J; Repérant C; Guiard BP; Guilloux JP; David DJ; Gardier AM
    Eur J Pharmacol; 2010 Feb; 628(1-3):83-90. PubMed ID: 19944680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine.
    Gur E; Lifschytz T; Van De Kar LD; Lerer B; Newman ME
    Psychoneuroendocrinology; 2004 Oct; 29(9):1172-83. PubMed ID: 15219641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat.
    Hervás I; Queiroz CM; Adell A; Artigas F
    Br J Pharmacol; 2000 May; 130(1):160-6. PubMed ID: 10781012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.